Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance.
- NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_assertion description "[If breast cancers arise independently in each breast the odds ratio (OR) for bilateral breast cancer for carriers of CHEK2 1100delC should be approximately 5.5, the square of the reported OR for a first primary (OR, 2.34).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance.
- NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_assertion evidence source_evidence_literature NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance.
- NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_assertion SIO_000772 19124502 NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance.
- NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_assertion wasDerivedFrom befree-20140225 NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance.
- NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_assertion wasGeneratedBy ECO_0000203 NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP252502.RA2VEgklnm0Zy0mfij7QomqMhIKPK4YkR2kxRFt9fK6vI130_provenance.